Biotech has reversed.
Inverse LABD, higher in pre-market, approx: +5%

There are essentially two scenarios:
First, IBB is retracing, gathering fuel for new highs
Second, IBB has reversed and is heading much lower
Target levels to be identified and reviewed in a subsequent update.
Charts by StockCharts